On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
We have now added a new section called the "Assay History List" to the "At A Gla...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...